CVRX
HealthcareCVRx, Inc.
$7.55+0.11 (+1.48%)
Prev Close
$7.44
Open
$7.39
High
$7.95
Low
$7.10
Volume
136.5K
Market Cap
$210.0M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at CVRx, Inc. (CVRX) has been dominated by buying, with 7 insider purchases totaling $1.67M and 5 insider sales totaling $457.2K. The most recent insider transaction was by Hykes Kevin (director, officer: PRES & CEO), who sold $122.7K worth of shares on Mar 3, 2026. CVRx, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $210.0M.
Buys (12M)
7
$1.67M
Sells (12M)
5
$457.2K
Net Activity
Net Buyer
$1.21M
Active Insiders
8
last 12 mo
CVRX Price Chart
CVRX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026↗ | Hykes Kevin | director, officer: PRES & CEO | Sell | 15,526 | $7.90 | $122.7K | 284,237 |
| Mar 3, 2026↗ | John Robert Allen | officer: Chief Revenue Officer | Sell | 7,928 | $7.90 | $62.7K | 86,036 |
| Mar 3, 2026↗ | OASHEIM JARED | officer: CHIEF FINANCIAL OFFICER | Sell | 3,488 | $7.90 | $27.6K | 96,703 |
| Mar 3, 2026↗ | VERRASTRO PAUL | officer: CHIEF MKTG & STRAT OFFICER | Sell | 2,568 | $7.90 | $20.3K | 60,551 |
| Feb 23, 2026↗ | Jain Mudit K. | director | Buy | 46,800 | $6.36 | $297.6K | 980,183 |
| Feb 20, 2026↗ | Jain Mudit K. | Director | Buy | 46,800 | $6.36 | $297.6K | 0 |
| Feb 18, 2026↗ | Jain Mudit K. | Director | Buy | 1,200 | $4.64 | $5.6K | 5,650 |
| Jan 8, 2026↗ | JOHNSON & JOHNSON | 10 percent owner | Sell | 22,337 | $10.03 | $224.0K | 4,031,200 |
| May 15, 2025↗ | Nielsen Kirk G. | Director | Buy | 10,966 | $5.45 | $59.8K | 0 |
| May 12, 2025↗ | Hykes Kevin | PRES & CEO | Buy | 5,000 | $4.84 | $24.2K | 0 |
| May 12, 2025↗ | Jain Mudit K. | Director | Buy | 1,650 | $4.71 | $7.8K | 0 |
| May 12, 2025↗ | Nielsen Kirk G. | Director | Buy | 187,813 | $5.20 | $977.3K | 0 |
| Nov 19, 2024↗ | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 1,430 | $13.58 | $19.4K | 0 |
| Aug 15, 2024↗ | SLATTERY JOSEPH P | Director | Buy | 3,000 | $8.10 | $24.3K | 0 |
| Aug 8, 2024↗ | SLATTERY JOSEPH P | Director | Buy | 3,000 | $8.24 | $24.7K | 0 |
| Aug 6, 2024↗ | SLATTERY JOSEPH P | Director | Buy | 2,500 | $9.09 | $22.7K | 0 |
| Aug 5, 2024↗ | Hykes Kevin | PRES & CEO | Buy | 30,000 | $8.36 | $250.8K | 0 |
| Feb 20, 2024↗ | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 2,545 | $21.90 | $55.7K | 0 |
| Feb 16, 2024↗ | JOHNSON & JOHNSON | 10% Owner | Sell | 611,450 | $0.31 | $192.2K | 0 |
| Aug 3, 2023↗ | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 628 | $18.55 | $11.7K | 0 |
| Jul 31, 2023↗ | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 1,122 | $17.49 | $19.6K | 0 |
| Nov 28, 2022↗ | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 4,600 | $11.94 | $54.9K | 0 |
| May 24, 2022↗ | Nielsen Kirk G. | Director | Buy | 8,070 | $5.05 | $40.8K | 0 |
| May 19, 2022↗ | Nielsen Kirk G. | Director | Buy | 28,795 | $5.04 | $145.0K | 0 |
| May 3, 2022↗ | Nielsen Kirk G. | Director | Buy | 62,304 | $5.99 | $373.5K | 0 |
| Apr 28, 2022↗ | Nielsen Kirk G. | Director | Buy | 42,088 | $5.97 | $251.3K | 0 |
| Feb 28, 2022↗ | Jain Mudit K. | Director | Buy | 600 | $9.03 | $5.4K | 0 |
| Feb 24, 2022↗ | Nielsen Kirk G. | Director | Buy | 3,400 | $8.24 | $28.0K | 0 |
| Feb 18, 2022↗ | Nielsen Kirk G. | Director | Buy | 104,867 | $7.97 | $836.0K | 0 |
| Nov 18, 2021↗ | Jain Mudit K. | Director | Buy | 1,175 | $14.39 | $16.9K | 0 |
| Aug 12, 2021↗ | Jain Mudit K. | Director | Buy | 625 | $19.72 | $12.3K | 0 |
| Jul 2, 2021↗ | GLAXOSMITHKLINE PLC | 10% Owner | Buy | 275,000 | $18.00 | $4.95M | 0 |
| Jul 2, 2021↗ | NEW ENTERPRISE ASSOCIATES 10 L P | 10% Owner | Buy | 225,500 | $18.00 | $4.06M | 0 |
| Jul 2, 2021↗ | Pardo Geoffrey B | Director | Buy | 275,000 | $18.00 | $4.95M | 0 |
| Jul 1, 2021↗ | Jain Mudit K. | Director | Buy | 223,222 | $18.03 | $4.03M | 0 |
| Jun 30, 2021↗ | NEHRA JOHN M | Director | Buy | 27,877 | $18.03 | $502.6K | 0 |
CVRX Insider Buying Activity
The following table shows recent insider purchases of CVRx, Inc. (CVRX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026↗ | Jain Mudit K. | director | Buy | 46,800 | $6.36 | $297.6K | 980,183 |
| Feb 20, 2026↗ | Jain Mudit K. | Director | Buy | 46,800 | $6.36 | $297.6K | 0 |
| Feb 18, 2026↗ | Jain Mudit K. | Director | Buy | 1,200 | $4.64 | $5.6K | 5,650 |
| May 15, 2025↗ | Nielsen Kirk G. | Director | Buy | 10,966 | $5.45 | $59.8K | 0 |
| May 12, 2025↗ | Hykes Kevin | PRES & CEO | Buy | 5,000 | $4.84 | $24.2K | 0 |
| May 12, 2025↗ | Jain Mudit K. | Director | Buy | 1,650 | $4.71 | $7.8K | 0 |
| May 12, 2025↗ | Nielsen Kirk G. | Director | Buy | 187,813 | $5.20 | $977.3K | 0 |
| Aug 15, 2024↗ | SLATTERY JOSEPH P | Director | Buy | 3,000 | $8.10 | $24.3K | 0 |
| Aug 8, 2024↗ | SLATTERY JOSEPH P | Director | Buy | 3,000 | $8.24 | $24.7K | 0 |
| Aug 6, 2024↗ | SLATTERY JOSEPH P | Director | Buy | 2,500 | $9.09 | $22.7K | 0 |
| Aug 5, 2024↗ | Hykes Kevin | PRES & CEO | Buy | 30,000 | $8.36 | $250.8K | 0 |
| May 24, 2022↗ | Nielsen Kirk G. | Director | Buy | 8,070 | $5.05 | $40.8K | 0 |
| May 19, 2022↗ | Nielsen Kirk G. | Director | Buy | 28,795 | $5.04 | $145.0K | 0 |
| May 3, 2022↗ | Nielsen Kirk G. | Director | Buy | 62,304 | $5.99 | $373.5K | 0 |
| Apr 28, 2022↗ | Nielsen Kirk G. | Director | Buy | 42,088 | $5.97 | $251.3K | 0 |
| Feb 28, 2022↗ | Jain Mudit K. | Director | Buy | 600 | $9.03 | $5.4K | 0 |
| Feb 24, 2022↗ | Nielsen Kirk G. | Director | Buy | 3,400 | $8.24 | $28.0K | 0 |
| Feb 18, 2022↗ | Nielsen Kirk G. | Director | Buy | 104,867 | $7.97 | $836.0K | 0 |
| Nov 18, 2021↗ | Jain Mudit K. | Director | Buy | 1,175 | $14.39 | $16.9K | 0 |
| Aug 12, 2021↗ | Jain Mudit K. | Director | Buy | 625 | $19.72 | $12.3K | 0 |
| Jul 2, 2021↗ | GLAXOSMITHKLINE PLC | 10% Owner | Buy | 275,000 | $18.00 | $4.95M | 0 |
| Jul 2, 2021↗ | NEW ENTERPRISE ASSOCIATES 10 L P | 10% Owner | Buy | 225,500 | $18.00 | $4.06M | 0 |
| Jul 2, 2021↗ | Pardo Geoffrey B | Director | Buy | 275,000 | $18.00 | $4.95M | 0 |
| Jul 1, 2021↗ | Jain Mudit K. | Director | Buy | 223,222 | $18.03 | $4.03M | 0 |
| Jun 30, 2021↗ | NEHRA JOHN M | Director | Buy | 27,877 | $18.03 | $502.6K | 0 |
CVRX Insider Selling Activity
The following table shows recent insider sales of CVRx, Inc. (CVRX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026↗ | Hykes Kevin | director, officer: PRES & CEO | Sell | 15,526 | $7.90 | $122.7K | 284,237 |
| Mar 3, 2026↗ | John Robert Allen | officer: Chief Revenue Officer | Sell | 7,928 | $7.90 | $62.7K | 86,036 |
| Mar 3, 2026↗ | OASHEIM JARED | officer: CHIEF FINANCIAL OFFICER | Sell | 3,488 | $7.90 | $27.6K | 96,703 |
| Mar 3, 2026↗ | VERRASTRO PAUL | officer: CHIEF MKTG & STRAT OFFICER | Sell | 2,568 | $7.90 | $20.3K | 60,551 |
| Jan 8, 2026↗ | JOHNSON & JOHNSON | 10 percent owner | Sell | 22,337 | $10.03 | $224.0K | 4,031,200 |
| Nov 19, 2024↗ | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 1,430 | $13.58 | $19.4K | 0 |
| Feb 20, 2024↗ | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 2,545 | $21.90 | $55.7K | 0 |
| Feb 16, 2024↗ | JOHNSON & JOHNSON | 10% Owner | Sell | 611,450 | $0.31 | $192.2K | 0 |
| Aug 3, 2023↗ | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 628 | $18.55 | $11.7K | 0 |
| Jul 31, 2023↗ | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 1,122 | $17.49 | $19.6K | 0 |
| Nov 28, 2022↗ | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Sell | 4,600 | $11.94 | $54.9K | 0 |
CVRX Insiders
Similar Stocks to CVRX
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
SYK
Stryker Corporation
$336.96-0.07%
$129.05B
MDT
Medtronic plc
$87.06-0.37%
$112.19B
BSX
Boston Scientific Corporation
$68.91+0.51%
$101.72B
EW
Edwards Lifesciences Corporation
$81.76-3.37%
$49.14B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$273.67-3.21%
$47.35B
DXCM
DexCom, Inc.
$64.51-1.15%
$25.45B
ZBH
Zimmer Biomet Holdings, Inc.
$93.20+0.77%
$18.47B